GMP Beta-Amyloid (1-42), human
- Cat.Number : AS-GMP-20276-1
- Manufacturer Ref. :
-
Availability :
In stock
Select specification
Aß (1-42), a major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains. Biochemical analysis of the amyloid peptides isolated from Alzheimer’s disease brain indicates that Aß (1-42) is the principal species associated with senile plaque amyloids, while Aß (1-40) is more abundant in cerebrovascular amyloid deposit.
This cGMP beta-Amyloid 1-42 peptide has been produced under conditions compliant with 21 CFR part 820 & ISO 13485 and is appropriate for use as an IVD component or as a quality control standard (not for human use).
QC attributes
Peptide Purity: =95%
Endotoxin: =1 EU/mg
Bioburden: Report Results (Lot specific)
Solubility: Aqueous media (see CoA)
Monomer content: =95%
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
CAS registry number |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Peptide Content |
|
Endotoxin content |
|
Storage & stability | |
Form |
|
Activity | |
Application | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Downloads
You may also be interested in the following product(s)


SensoLyte® 520 Neprilysin Activity Assay Kit Fluorimetric - 1 kit
